This page shows the publications co-authored by Jean Connors and Paul Ridker.
Antithrombotic prophylaxis for symptomatic outpatients with COVID-19: less is consistently more. Lancet Haematol. 2022 08; 9(8):e551-e553.
Clinical predictors of COVID-19 severity and bleeding in the ACTIV-4B COVID-19 outpatient thrombosis prevention trial. Am J Hematol. 2022 07; 97(7):E235-E240.
Thromboinflammation and Antithrombotics in COVID-19: Accumulating Evidence and Current Status. JAMA. 2022 04 05; 327(13):1234-1235.
Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial. JAMA. 2021 11 02; 326(17):1703-1712.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.